![SonomaEye-full-color-vector[2].png](https://static.wixstatic.com/media/bed00b_da20b9cc704044b0b048ac8ef9190470~mv2_d_3024_2195_s_2.png/v1/fill/w_169,h_123,al_c,usm_0.66_1.00_0.01,blur_3/SonomaEye-full-color-vector%5B2%5D.png)
Retina 2
Saturday, 3/23/2019
08:00 AM - 09:30 AM
Moderators: David Sarraf and Carolyn Pan
9 minutes for each presentation and 3 minutes for discussion after each presentation
-
8:00 am - 8:12 am: Genetics of Diabetic Retinopathy (Lucia Sobrin, MD, MPH)
-
8:12 am - 8:24 am: Diabetic Macular Edema: Challenges in Current Treatments (Carolyn K. Pan, MD)
-
8:24 am - 8:36 am: Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Diabetic Macular Edema: A “Real World” Analysis in 28,456 Eyes (Thomas Ciulla, MD, MBA)
-
8:36 am - 8:48 am: Brolucizumab: Is Dryer Better? (Diana V. Do, MD)
-
8:48 am - 9:00 am: PAMM and the Ischemic Cascade: Understanding the Organization of the Retinal Capillary Plexus (David Sarraf, MD)
-
9:00 am - 9:12 am: How Do We Manage Rejection in RPE Transplantation (Jose S. Pulido, MD)
-
9:12 am - 9:24 am: A Novel Method of Sustained Antibody Delivery Using an Anchoring Molecule (Ira Schachar, MD)
-
9:24 am - 9:30 am: Discussion